Asia Chang Email & Phone Number

California, United States

South San Francisco, California, Us

• Strategic role on leadership team navigating Freenome from post-Series A through Series E growth • Orchestrate focused execution for organizational achievement by driving the corporate strategy through a strategic planning, goal alignment, and quarterly business review process to scale the enterprise • Define and develop the Freenome CRC screening clinical test service by integrating patient, primary care, gastroenterology, phlebotomy, payer, and population health economics input to shape the solution • Establish the product development process along with a system-level, programmatic approach to enable robust early to late stage product development collaboration and decision-making• Build functions from ground-up for product management (to define the clinical test), technical product management (to develop the software system and AI/ML pipelines), and program management (to drive the collaboration and development process)

Waltham, Ma, Us

• Oncology business leader within the Clinical Next-Generation Sequencing Division, growing number of products by 4x and revenue at 30%+• Lead product management team for Oncomine NGS cancer assays on the Ion Torrent NGS platform and the diagnostics biopharma partnering team enabling Companion Diagnostics (CDx)• Launch of the Oncomine Dx Target Test, the first FDA-approved NGS CDx for multiple therapies indicated for non-small cell lung cancer (NSCLC)• Support national precision medicine efforts such as the NCI-MATCH precision medicine trial, NCI-COG Pediatric MATCH, and Japan SCRUM clinical trials• Pioneering liquid biopsy solutions with the family of Oncomine cfDNA assays• Spearheading roadmap for Immuno-Oncology assays launching the first distributed Tumor Mutation Burden (TMB) assay and complete TCR-Repertoire profiling assay• Lead development of 5-year Next-Generation Sequencing (NGS) oncology precision medicine and diagnostics strategy • Lead Thermo Fisher's first NGS CDx agreement with Novartis and Pfizer

Boston, Ma, Us

• Rapid advancement from Associate (analyst level) to Engagement Manager (director level) in ~4.5 years (4 fast-track promotions; typically 6+ years)• Exceptional leader and mentor managing multiple teams of 3-10; responsible for delivery of entire projects to executive level global clients (45+ projects / 25+ clients)• Build strong relationships and influence stakeholders with clients for new business development including new project sourcing, proposal development, and client pitches to secure new projects • Effective communicator leading cross-functional teams by simplifying complex concepts and persuading with a combination of brevity and clarity• Lead investment and partnership assessments to support strategic transactions including market opportunity identification, M&A screens, and target due diligence resulting in deals ranging in size from $28.5M - $6.7B• Focused on long term growth objectives to drive value creation (e.g., business model innovation, commercial due diligence, partner-licensing support, strategic planning, market opportunity and segmentation)• Deep knowledge-base working with teams across entire development value chain ranging from R&D phase projects to product life-cycle management• Extensive experience across multiple life science industry sub-sectors supporting clients in biopharma (small molecule, biologics, and biosimilars), specialty pharma, implantable medical devices, hospital equipment, diagnostics, molecular diagnostics (MDx), research tools, genomics, and digital health• Broad disease expertise directly leading market oriented projects across 9+ therapeutic areas (TAs) including oncology, immunology, cardiology, diabetes, infectious diseases, nephrology, haematology, respiratory, and neurology

New Brunswick, Nj, Us

• Lead process development bioengineer (e.g., build, prototype, manufacture, test) for the Enterprise Vascular Reconstruction Device to treat wide neck aneurysms from research through Phase I clinical trials submitted and approved under an HDE• Product concept development and prototyping, preclinical testing, and IP portfolio development for a proof of concept device treating diffuse emphysema and COPD resulting in 10+ patents and the spinout of a startup company

Bs, Materials Science And Engineering

Master Of Business And Science (M.B.S.)